Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Biopharma Business Development Clinical trials
Five lessons learned deploying agentic AI in the life sciences Five lessons learned deploying agentic AI in the life sciences
Blog April 30, 2026
Five lessons learned deploying agentic AI in the life sciences
AI
Target selection and safety assessment: Navigating early decisions that shape drug development Target selection and safety assessment: Navigating early decisions that shape drug development
Blog March 27, 2026
Target selection and safety assessment: Navigating early decisions that shape drug development
Development Pharma Regulatory
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Blog March 26, 2026
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
GLP-1 Metabolic
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Gerontology
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
FDA Regulatory Safety

Biopharma

Blog February 27, 2018
PolyPEPI-1018: A hopeful advance in the fight against cancer – and a milestone for us
Meet the Millennial Physicians – Young, Mobile, and Harder to Reach Meet the Millennial Physicians – Young, Mobile, and Harder to Reach
Blog February 13, 2018
Meet the Millennial Physicians – Young, Mobile, and Harder to Reach
Blog February 12, 2018
Acorda and Sunovion: Coming to the "Rescue" in Parkinson's Disease?
Blog February 6, 2018
Modern tools to advance generic drug development and review
Blog February 2, 2018
Life sciences licensing deals in the fourth quarter of 2017: updates and trends
Blog January 22, 2018
Steps taken to streamline regulatory processes in the Middle East
Blog January 17, 2018
Sublocade approval likely to be a game changer in the U.S. fight against opioid addiction
Blog January 9, 2018
Predictive analytics yield better disease forecasting: the example of MS
Blog December 8, 2017
How can pharma reps respect physicians’ time? We asked 20 doctors
Blog November 30, 2017
Green light to market Hemlibra for hemophilia A with inhibitors in the US